Background illustration for clinical trials search

Geographic Atrophy Clinical Trials

Browse 32 Geographic Atrophy clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

for
Geographic Atrophy (GA)
Location: East Weymouth MA, The Woodlands TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50+

Code: NCT07230834

Phase1, Recruiting

A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Ottawa, Erie PA
Sponsor: Kriya Therapeutics, Inc.

Sex: All

Age: 55 - 70+

Code: NCT06765980

Phase1, Phase2, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

SGLT2 Inhibitors in Geographic Atrophy

for
Retinal Degeneration, Retinal Diseases, Eye Diseases,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 50+

Code: NCT07174687

Phase2, Recruiting

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

for
Dry Age-related Macular Degeneration, Geographic Atrophy
Location: Lemont IL, The Woodlands TX, Austin TX,
Sponsor: Regenerative Patch Technologies, LLC

Sex: All

Age: 55 - 70+

Code: NCT06557460

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Boston MA, Waltham MA, Worcester MA, Springfield MA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting
Featured

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

for
Geographic Atrophy, Age-Related Macular Degeneration
Location: Carmel IN, The Woodlands TX, Dallas TX, Abilene TX,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07160179

Phase1, Phase2, Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Hagerstown MD, Wildwood FL, The Woodlands TX,
Sponsor: ADARx Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT06990269

Phase2, Recruiting

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

for
Retinitis Pigmentosa, Choroideremia,
Location: Irvine CA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06375239

Recruiting

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

for
Retinitis Pigmentosa, Stargardt Macular Dystrophy,
Location: Irvine CA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07502664

Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase2, Recruiting

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy
Location: Bethlehem PA, Towson MD, Chevy Chase MD, Hagerstown MD,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07215234

Phase1, Phase2, Recruiting

What are geographic atrophy clinical trials?

Geographic atrophy clinical trials test ways to slow the loss of retinal cells, most often by calming an overactive part of the immune system called the complement pathway. Some trials study people in the earlier stages of the disease to see whether starting treatment sooner preserves more vision over time.

Why are clinical trials important for geographic atrophy research?

Who can participate in geographic atrophy clinical trials?

What types of geographic atrophy clinical trials are there?

Is geographic atrophy the same as macular degeneration?

Can geographic atrophy be confused with other eye conditions?

Is it safe to participate in geographic atrophy clinical trials?

Are geographic atrophy clinical trials paid?